FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

25887211000001108: Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Sep 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
83038101000001113 Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
83038201000001118 Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) Is a Product containing precisely promazine hydrochloride 25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) Has active ingredient Promazine hydrochloride false Inferred relationship Existential restriction modifier
Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) Has specific active ingredient Promazine hydrochloride true Inferred relationship Existential restriction modifier
Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) 100 tablet Has AMP True Promazine 25mg tablets (Icarus Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start